Featured ArticlesPsoriasis

Topical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature

By August 27, 2020No Comments

Featured Article

Featured Article

The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and impressive commercially driven popularization of a variety of cannabinoid preparations including topical forms such as creams, salves, lotions, lubricants, and many others.

Read more

This report details a case of a young man with psoriasis managed with topical cannabinoids.

Adam J. Friedman MD, Kimia Momeni BS, Mikhail Kogan MD

 

The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and impressive commercially driven popularization of a variety of cannabinoid preparations including topical forms such as creams, salves, lotions, lubricants, and many others.

However, while the market is exponentially growing, the rate at which mechanistic and clinical evidence supporting the use of cannabinoids in a litany of diseases is significantly slower. In fact, Robinson et al highlighted significant gaps in dermatologists understanding of the biology of cannabinoids and comfort with this space, further highlighting the great need to disseminate information throughout the medical community.

Along this vein, we present a case of a young man with psoriasis managed with topical cannabinoids.

View Case Study Now
Article Cited in this Post

You May Also Like

Shots, Shots, Shots: Is There Such a Thing as One Too Many?

| Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Dr. Joseph Bax Corticosteroid injections are everywhere in musculoskeletal medicine. Epidurals, joints, facets, bursae: when inflammation and pain are the targets, steroids have long been one of the sharpest…

JDD in the News: UV Light as a Workplace Hazard

| Featured Articles, JDD in the Media, Latest News | No Comments
Healio featured two Journal of Drugs in Dermatology studies in recent articles, including an article on UV light as an underappreciated workplace hazard. The study, "Sun Exposure and Cancer Outcomes…
Journal of Drugs in Dermatology JDD featuring Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis

Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis

| Featured Articles, Latest News, Psoriasis, Skin Cancer | No Comments
Navigating Systemic Psoriasis Therapies and Skin Cancer Risk: New JDD Insights  Have you read this article from the JDD? For clinicians managing moderate to severe psoriasis, balancing long term disease…

Leave a Reply